Stammdaten
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
Unternehmen & Branche
| Name | Anebulo Pharmaceuticals, Inc. |
|---|---|
| Ticker | ANEB |
| CIK | 0001815974 |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 17,4 Mio. USD |
| Beta | -1,62 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | -1,999,397 | -0.05 | 9,421,997 | 7,936,351 | |
| 2025-09-30 | 10-Q | -2,158,354 | -0.05 | 10,701,039 | 9,737,218 | |
| 2025-06-30 | 10-K | -8,484,763 | -0.25 | 12,145,616 | 11,657,928 | |
| 2025-03-31 | 10-Q | -1,676,169 | -0.04 | 14,008,484 | 13,462,452 | |
| 2024-12-31 | 10-Q | -2,463,030 | -0.09 | 15,841,220 | 14,962,421 | |
| 2024-09-30 | 10-Q | -2,200,736 | -0.08 | 2,467,940 | 1,898,715 | |
| 2024-06-30 | 10-K | -8,201,703 | -0.32 | 4,073,114 | 3,812,531 | |
| 2024-03-31 | 10-Q | -1,653,542 | -0.06 | 5,995,635 | 4,985,314 | |
| 2023-12-31 | 10-Q | -2,717,369 | -0.11 | 7,500,773 | 6,487,217 | |
| 2023-09-30 | 10-Q | -2,480,823 | -0.10 | 9,047,884 | 8,331,324 | |
| 2023-06-30 | 10-K | -11,732,338 | -0.47 | 11,670,151 | 10,601,350 | |
| 2023-03-31 | 10-Q | -2,797,971 | -0.11 | 14,432,606 | 12,941,521 | |
| 2022-12-31 | 10-Q | -3,826,952 | -0.15 | 16,888,256 | 15,515,855 | |
| 2022-09-30 | 10-Q | -2,611,835 | -0.11 | 19,815,365 | 19,117,186 | |
| 2022-06-30 | 10-K | -6,825,619 | 0.29 | 15,579,431 | 15,066,900 | |
| 2022-03-31 | 10-Q | -1,876,491 | 17,248,467 | 17,162,690 | ||
| 2021-12-31 | 10-Q | -1,072,991 | 18,963,871 | 18,913,927 | ||
| 2021-09-30 | 10-Q | -1,553,395 | 20,500,342 | 19,892,636 | ||
| 2021-06-30 | 10-K | -30,252,554 | 21,653,491 | 21,411,858 | ||
| 2021-03-31 | 10-Q | -555,832 | 4,291,475 | -9,435,836 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.